Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
-
761
-
762
-
763
Specifications and outcomes of clinical trial studies included in the meta-analysis.
Published 2025Subjects: -
764
-
765
-
766
Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia...
Published 2025Subjects: “…treatment initiation decreased…”
-
767
Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019).
Published 2025Subjects: “…treatment initiation decreased…”
-
768
Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later.
Published 2025Subjects: “…treatment initiation decreased…”
-
769
Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year.
Published 2025Subjects: “…treatment initiation decreased…”
-
770
General information of patient who diagnosis insomnia disorder (N = 518,119).
Published 2025Subjects: “…treatment initiation decreased…”
-
771
Detailed treatment status of people who received non- pharmacological treatment at first diagnosis.
Published 2025Subjects: “…treatment initiation decreased…”
-
772
Treatment at first diagnosis of insomnia disorder (%).
Published 2025Subjects: “…treatment initiation decreased…”
-
773
-
774
Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate).
Published 2025“…<p>Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate).…”
-
775
-
776
Cyclosporin A significantly reduces the survival rate and completely inhibits the formation of multicellular aggregates in tolerant strains under caspofungin stress.
Published 2025“…<p>(A) Cyclosporin A decreases the survival rate of tolerant strains under caspofungin. …”
-
777
-
778
-
779
-
780
Sodium level changes in matched restaurant menu items (2016–2020) by UK NSRI food category.
Published 2025Subjects: